Valuation Tonix Pharmaceuticals Nasdaq

Stocks

End-of-day quote Nasdaq Other stock markets 2024-02-05			5-day change	1st Jan Change
0.3222 ^USD	-2.36%		+2.32%	-20.05%

06-08	Tonix Pharmaceuticals Enters Second Commercial Payer Deal, Expands Drug Coverage	MT
06-08	Tonix Pharmaceuticals Holding Corp. Enters Agreement With Group Purchasing Organization For Commercial Coverage Of TONMYA	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	177.4	22.42	23.62	61.64	193.6	210.7	-	-
Change	-	-87.36%	5.35%	160.94%	214.02%	8.88%	-	-
Enterprise Value (EV)	177.4	22.42	23.62	61.64	193.6	210.7	210.7	210.7
Change	-	-87.36%	5.35%	160.94%	214.02%	8.88%	0%	0%
P/E	-1.38x	-0.12x	-0.06x	-0.19x	-1.07x	-1.29x	-2.13x	-5.6x
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	0x	0x	0x	0x	0.1x	0.1x
Capitalization / Revenue	-	-	3.04x	6.11x	14.8x	6.16x	2.67x	1.29x
EV / Revenue	-	-	0x	0x	0x	6.16x	2.67x	1.29x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-1.23x	-1.37x	-2.21x
EV / FCF	-	-	-	-	-	-1.05x	-1.03x	-1.24x
FCF Yield	-	-	-	-	-	-94.9%	-97.3%	-80.7%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-166,400	-65,400	-21,920	-176.6	-14.57	-10.27	-6.2	-2.36
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	7.768	10.09	13.11	34.18	78.93	163
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-92.31	-112.1	-118.4	-136.7	-125.7	-171.7	-153.8	-95.22
Net income ¹	-92.29	-116.9	-116.7	-130	-124	-170	-151.8	-85.5
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	228,928.00	7,796.00	1,289.60	32.98	15.62	13.22	13.22	13.22
Nbr of stocks (in thousands)	0.78	2.88	18.3	1,869	12,392	15,941	-	-
Announcement Date	3/14/22	3/13/23	4/1/24	3/18/25	3/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.2x	12.84x	26.1x	0.57%	1,077B
JOHNSON & JOHNSON	27.22x	6.26x	17.02x	2.1%	613B
ABBVIE INC.	32.17x	7.47x	15.29x	2.73%	448B
ROCHE HOLDING AG	17.9x	4.45x	10.94x	2.98%	332B
ASTRAZENECA PLC	23.72x	4.94x	14x	1.76%	293B
NOVARTIS AG	21.69x	5.59x	13.51x	2.83%	286B
NOVO NORDISK A/S	14.19x	5.21x	10.72x	3.54%	215B
AMGEN INC.	23.3x	6.21x	10.84x	2.81%	193B
GILEAD SCIENCES, INC.	-45.82x	5.53x	30.47x	2.54%	159B
Average	16.62x	6.50x	16.54x	2.43%	401.79B
Weighted average by Cap.	24.44x	7.95x	18.32x	1.97%